Empower Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7M Buy
21,311
+1,831
+9% +$879K 0.03% 174
2026
Q1
$9.58M Sell
19,480
-3,279
-14% -$1.78M 0.02% 167
2025
Q4
$13.2M Buy
22,759
+3,197
+16% +$1.81M 0.04% 155
2025
Q3
$9.49M Sell
19,562
-401
-2% -$187K 0.03% 168
2025
Q2
$8.09M Buy
19,963
+1,131
+6% +$473K 0.02% 169
2025
Q1
$9.37M Buy
18,832
+319
+2% +$173K 0.03% 166
2024
Q4
$9.63M Sell
18,513
-171
-0.9% -$94K 0.03% 165
2024
Q3
$11.6M Sell
18,684
-150
-0.8% -$88.8K 0.04% 154
2024
Q2
$10.4M Sell
18,834
-651
-3% -$373K 0.04% 156
2024
Q1
$11.3M Sell
19,485
-532
-3% -$299K 0.04% 156
2023
Q4
$10.6M Sell
20,017
-197
-1% -$95.4K 0.04% 166
2023
Q3
$10.2M Buy
20,214
+16,648
+467% +$8.87M 0.05% 155
2023
Q2
$1.86M Sell
3,566
-95
-3% -$51.3K 0.01% 208
2023
Q1
$2.09M Buy
+3,661
New +$2.06M 0.01% 215

Other funds holding TMO

Empower Advisory Group's TMO Position: Q2 2026 in Review

Empower Advisory Group increased its Thermo Fisher Scientific (TMO) stake by 9.4% in Q2 2026, buying an estimated $879K and bringing the position to 21,311 shares worth $10.7M. The position accounts for 0.03% of the portfolio, ranked #174.

Empower Advisory Group first reported a position in TMO in Q1 2023 and has held it in 14 quarters since. The position peaked at $13.2M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Empower Advisory Group held 21,311 shares of Thermo Fisher Scientific worth $10.7M as of Q2 2026.
  • Empower Advisory Group bought 1,831 Thermo Fisher Scientific shares in Q2 2026, an estimated $879K.
  • Thermo Fisher Scientific made up 0.03% of Empower Advisory Group's portfolio in Q2 2026, its #174 holding.
  • Empower Advisory Group first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 14 quarters since.
  • Empower Advisory Group's Thermo Fisher Scientific position peaked at $13.2M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Empower Advisory Group's 13F filing for Q2 2026, filed 12 Aug 2026.